Dr. Rachel Butler: NGS, an enabling technology for pathology labs | Illumina Webinar

Dr. Rachel Butler, Head of the All Wales Genetics Laboratory discusses her rationale for adopting Illumina next-generation-sequencing (NGS) http://www.illumina.com/areas-of-inte... and reviews its advantages in molecular pathology for profiling solid tumor samples. She shares her perspective on both traditional testing methods and the benefits of NGS. http://www.illumina.com/content/dam/i... Dr. Butler reveals how iterative sample testing was taking a toll on their lab. Now with Illumina NGS workflows, http://www.illumina.com/areas-of-inte... they use a single, cost-effective process for all their gene targets, which has dramatically improved productivity. Dr. Butler also highlights the Clinical NGS Consortium for Solid Tumours, a forum that’s establishing NGS best practices for European laboratories.
Webinar at a glance
• A first-hand report of NGS implementation in a molecular genetics lab, including panel design and analysis tools
• An overview of the benefits of NGS vs. traditional methods
• Expert insights from a member of the Clinical NGS Consortium for Solid Tumours
Presenter:
Dr. Rachel Butler
Head of Laboratory
All Wales Genetics Laboratory http://www.wales.nhs.uk/sites3/home.c...


View related webinars
Next-Generation Sequencing of FFPE Tumor Specimens | Illumina Video
   • Next-Generation Sequencing of FFPE Tu...  

Advancing pathology and cancer research with next-generation sequencing | Illumina Video
   • Advancing pathology and cancer resear...  

The MiniSeq™ System, a Simple, Affordable Sequencing Solution | Illumina Video
   • The MiniSeq™ System, a Simple, Afford...  

Subscribe to the Illumina video channel http://www.youtube.com/subscription_c...